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Summary
 
The first checkpoint in T cell development occurs between the CD4
 
2
 
CD8
 
2
 
 and CD4
 
1
 
CD8
 
1
 
stages and is associated with formation of the pre-T cell receptor (TCR). The signaling mech-
anisms that drive this progression remain largely unknown. Here, we show that extracellular
signal–regulated kinases (ERKs)-1/2 are activated upon engagement of the pre-TCR. Using a
novel experimental system, we demonstrate that expression of the pre-TCR by developing
thymocytes induces ERK-1/2 activation within the thymus. In addition, the activation of this
pre-TCR signaling cascade is mediated through Lck. These findings directly link pre-TCR
complex formation with specific downstream signaling components in vivo.
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D
 
uring the maturation of T lymphocytes within the thy-
mus, precursor lymphocytes undergo two key selection
steps that ensure that T cells express a functional TCR–
CD3 complex on their cell surfaces that can recognize pep-
tide antigens in the context of self-MHC (1). The earliest
thymocytes, which migrate to the thymus from the adult
bone marrow or fetal liver, lack expression of CD4 and CD8
and are thus termed CD4
 
2
 
CD8
 
2
 
 double-negative (DN)
 
1
 
cells (2). The DN stage of development can be further sub-
divided by the ordered surface expression of CD117 (c-kit)
and CD25 as follows: CD117
 
1
 
CD25
 
2
 
, CD117
 
1
 
CD25
 
1
 
,
CD117
 
lo/
 
2
 
CD25
 
1
 
, and CD117
 
2
 
CD25
 
2
 
 (2, 3).
The first developmental checkpoint in T cell differentia-
tion, which occurs at the CD117
 
lo/
 
2
 
CD25
 
1
 
 stage, assures
that only thymocytes with a productively rearranged TCR
 
b
 
 chain proceed to the next developmental stage. This crit-
ical regulatory checkpoint is known as 
 
b
 
-selection (4–6).
The TCR 
 
b
 
 chain covalently associates with the nonpoly-
morphic pre-T
 
a
 
 (pT
 
a
 
) chain, which together with CD3
molecules forms the pre-TCR complex (7, 8). Expression
of the pre-TCR triggers a differentiation program that in-
cludes inhibition of further V(D)J recombination at the
TCR-
 
b
 
 locus (allelic exclusion), rescue from apoptosis, ex-
ponential cellular proliferation, downregulation of CD25
expression, CD4 and CD8 surface expression, and initia-
tion of TCR-
 
a
 
 gene rearrangement (9–14). Notably, dif-
ferentiation toward the CD4
 
1
 
CD8
 
1
 
 double-positive (DP)
stage of development occurs through an immature single-
positive (SP) stage (5, 6, 15, 16). The second regulatory
checkpoint in T cell development occurs at the DP stage
when thymocytes undergo positive and negative selection,
resulting in the generation of mature CD4
 
1
 
CD8
 
2
 
 and
CD4
 
2
 
CD8
 
1
 
 SP thymocytes (1).
The signaling pathways that mediate 
 
b
 
-selection events
are not well defined. However, the study of T cell devel-
opment in mice lacking key signaling molecules has pro-
vided important clues regarding the possible signal trans-
duction pathways essential for 
 
b
 
-selection. The pre-TCR
complex seems to function together with CD3 molecules
to transduce differentiation and proliferation signals (16–23).
Downstream signaling events appear to be dependent on
the nonreceptor tyrosine kinases Lck/Fyn and ZAP-70/Syk
(15, 24–28), as well as the adapter proteins SLP-76 (SH2
domain–containing leukocyte protein, 76 kD) and LAT
(linker for activation of T cells) (29–31). Indeed, genetic
deficiencies for pT
 
a
 
, TCR-
 
b
 
, CD3
 
e
 
, CD3
 
g
 
, Lck, SLP-76,
and LAT all arrest differentiation at the CD117
 
lo/
 
2
 
CD25
 
1
 
stage, at the onset of 
 
b
 
-selection (16, 20, 24, 29–33).
Thymocytes are also arrested at the CD117
 
2
 
CD25
 
1
 
stage of development in recombination activating gene 1 or
2–deficient (RAG
 
2
 
/
 
2
 
) and SCID mice due to an inability
 
1
 
Abbreviations used in this paper:
 
 DLR, DNA loading ratio; DN, double-
negative; DP, double-positive; ERK, extracellular signal–regulated kinase;
FTOC, fetal thymic organ culture; LAT, linker for activation of T cells;
MAPK, mitogen-activated protein kinase; RAG, recombination activating
gene; RLUs, relative light units; SLP-76, SH2 domain–containing leuko-
cyte protein, 76 kD; SP, single-positive. 
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to initiate or complete rearrangement of their antigen re-
ceptors, respectively (34–38). In particular, the introduc-
tion of productively rearranged TCR-
 
b
 
 transgenes into
RAG
 
2
 
/
 
2
 
 and SCID mice allows further differentiation of
DN cells, indicating that a functional TCR 
 
b
 
 chain is suf-
ficient for progression to the DP stage in these mice (39,
40). However, RAG
 
2
 
/
 
2
 
 mice containing constitutively ac-
tive Lck (F505), Ras (Ha-Ras
 
V12
 
), and serine/threonine kinase
c-Raf-1 (Raf-CAAX) transgenes allow for cellular prolifer-
ation and generation of DP cells by experimentally bypass-
ing pre-TCR–dependent 
 
b
 
-selection processes (41–43).
These data support the involvement of Lck, Ras, and Raf
in 
 
b
 
-selection and suggest a signaling mechanism similar to
that observed during T cell activation. Signaling through
the mature 
 
a/b
 
 TCR is thought to involve the following
events after TCR engagement: Lck-mediated phosphoryla-
tion of the CD3 
 
z
 
 chain; recruitment of ZAP-70/Syk to
the receptor complex; ZAP-70/Syk-mediated phosphory-
lation of downstream substrates, including LAT, SLP-76,
and phospholipase C 
 
g
 
1; linkage of the TCR–CD3 complex
to pathways leading to Ca
 
2
 
1
 
 mobilization and Ras activation
through phosphorylated LAT and SLP-76; and activation of
the Ras/Raf/mitogen-activated protein kinase (MAPK)-1
(MEK1)/extracellular signal–regulated kinase (ERK; p44/42
MAPK) cascade (44). Notably, results from transgenic mice
carrying dominant negative forms of Ras (Ha-Ras
 
N17
 
; refer-
ence 45), Raf (46), and MEK1 (47) did not affect 
 
b
 
-selection
events. Thus, studies supporting the involvement of the
Ras/Raf/MEK/ERK cascade during 
 
b
 
-selection are con-
flicting. Furthermore, a direct link between pre-TCR ex-
pression by developing thymocytes and the activation of
downstream signaling pathways has not been demonstrated.
In this report, we show that ERK-1/2 is phosphorylated
and activated upon engagement of the pre-TCR expressed
on a SCID mouse–derived pre-T cell line, indicating that
the ERK signaling cascade is initiated by the pre-TCR. To
study specific biochemical signaling events that ensue upon
formation of the pre-TCR complex, we developed a novel
experimental system that allows for the introduction of re-
porter plasmids into thymic lobes. This system enables sig-
nals generated by the pre-TCR to be assayed in real time
within a biologically relevant setting, i.e., during thymo-
cyte differentiation within an intact thymus. Using this sys-
tem, we demonstrate that the ERK signaling cascade is ac-
tivated in developing thymocytes as a physiological result
of pre-TCR complex formation in vivo.
 
Materials and Methods
 
Animals.
 
RAG-2
 
2
 
/
 
2
 
 mice were bred and maintained in our
animal facility (34). Timed-pregnant RAG-2
 
2
 
/
 
2
 
 mice were used
on day 14 of gestation.
 
Cell Lines.
 
The SL-12
 
b
 
.12 cell line is a pre-T cell line de-
rived from a spontaneous SCID mouse–derived thymoma that
stably expresses functionally rearranged TCR 
 
b
 
 chain at the cell
surface with endogenous pT
 
a
 
 to form a pre-TCR (48, 49). The
cell line was maintained in complete media (HG-DME media
containing 10% FBS, 1% penicillin/streptomycin, 1% glutamine,
 
1% sodium pyruvate, 1% Hepes, 0.1% 2-ME, and 0.1% gentami-
cin [GIBCO BRL] supplemented with 0.5 mg/ml geneticin
[GIBCO BRL]). Cells were kept in a humidified atmosphere of
5% CO
 
2 
 
at 37
 
8
 
C.
 
SDS-PAGE and Western Blot Analysis.
 
SL-12
 
b
 
.12 cells (5 
 
3
 
10
 
6
 
) were incubated at 4
 
8
 
C with 10 
 
m
 
g/ml biotinylated anti–
TCR-
 
b
 
 mAb (H57-597) for 30 min in DMEM supplemented
with 0.1% BSA. Cells were then washed, resuspended in 100 
 
m
 
l
DMEM/0.1% BSA containing 25 
 
m
 
g/ml avidin (Sigma Chemi-
cal Co.), and incubated at 37
 
8
 
C. Stimulation was stopped by the
addition of 3 ml ice cold PBS followed by lysis in buffer contain-
ing 50 mM Tris, pH 7.4 (Boehringer Mannheim), 0.5% Triton
X-100 (Boehringer Mannheim), 150 mM NaCl (ICN Biomedi-
cals Inc.), 1 mM EDTA (BDH Chemicals Ltd.), 1 mM sodium
orthovanadate (ICN Biomedicals Inc.), and Complete Inhibitor
Cocktail (Boehringer Mannheim). Control cells (unstimulated)
were treated similarly; however, avidin was not added before ly-
sis. Lysates were resolved on 10% SDS-PAGE under reducing
conditions and transferred onto polyvinylidene difluoride mem-
branes (Immobilon-P; Amersham Pharmacia Biotech). Phosphor-
ylated ERK-1 (p44 MAPK) and ERK-2 (p42 MAPK) and total
ERK-2 proteins were detected using phospho-p44/22 MAPK
(Thr202/Tyr204) mAb (New England Biolabs Inc.) and total p42
MAPK antibody (New England Biolabs Inc.), followed by horse-
radish peroxidase–conjugated goat anti–rabbit IgG (Santa Cruz
Biotechnology). Blots were revealed using Supersignal West Pico
chemiluminescent substrate (Pierce Chemical Co.).
 
Transfection of SL-12
 
b
 
.12 Cells.
 
All electroporations were
carried out using a BTX Electro Cell Manipulator 600 apparatus.
SL-12.
 
b
 
12 cells were electroporated at 450 
 
m
 
F, 186 
 
V
 
, 300 V,
attaining a time constant of 
 
z
 
30 ms. 3 
 
3
 
 10
 
6
 
 cells were trans-
fected with desired plasmid DNA (up to 40 
 
m
 
g), as indicated in
the figure legends. Each sample was transfected with PathDetect
reporter plasmids (Stratagene, Inc.; as indicated in figure legends)
and 1 
 
m
 
g plasmid encoding 
 
b
 
-galactosidase (pCMV-
 
b
 
-gal). The
addition of a fixed amount of 
 
b
 
-galactosidase plasmid allowed for
the control of transfection efficiency during the experiment. The
 
b
 
-galactosidase activity was used to index the luciferase signal de-
tected, as we were able to assay for luciferase and 
 
b
 
-galactosidase
activity within the same sample (50). In brief, cells were washed
in electroporation media (RPMI 1640 containing 20% FCS) and
resuspended at 1.2 
 
3
 
 10
 
7
 
 cells/ml (250 
 
m
 
l per transfection). DNA
and cells were combined in 4-mm sterile cuvettes (Bio-Rad
Labs.) and incubated on ice for 10 min. The cells were electropo-
rated with the conditions noted above and incubated on ice for a
further 10 min. Transfected cells were put into fresh complete
media and incubated for 24 h at 37
 
8
 
C, with or without the addi-
tion of exogenous stimuli, as indicated in the figure legends. The
cells were then lysed and analyzed for luciferase and 
 
b
 
-galactosi-
dase activity.
 
Gene Gun Transfection and Fetal Thymic Organ Culture.
 
Fetal thy-
mic lobes from timed-pregnant RAG-2
 
2
 
/
 
2
 
 mice at day 14 of gesta-
tion were placed on nucleopore filters resting on Gelfoam rafts (Up-
john) soaked in fetal thymic organ culture (FTOC) media
(complete media supplemented with a further 5% FCS; five to six
lobes per filter) (51). The thymic lobes were incubated at 37
 
8
 
C for
6 h in a humidified incubator with 5% CO
 
2
 
 to allow them to adhere
to the filters. After this time, the filters were briefly removed from
the Gelfoam rafts, and thymi were immediately transfected by gene
gun bombardment with a Helios gene gun set at 200 psi (Bio-Rad
Labs.), with the desired DNA bound to gold particles (1 
 
m
 
g gold)
(as indicated in the figure legends; one cartridge per set of thymic
lobes). The amount of DNA loaded per microgram of microcarriers 
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is referred to as the DNA loading ratio (DLR; see figure legends).
The filters carrying the transfected thymic lobes were then placed
back on the Gelfoam rafts and incubated at 37
 
8
 
C for the indicated
time (see figure legends). For short-term biochemical readout assays,
the thymic lobes were incubated for a further 16–20 h, and then a
single-cell suspension was prepared and the cells were lysed and as-
sayed for luciferase and b-galactosidase activities as described below.
For long-term developmental progression studies, the transfected
thymic lobes were incubated for 7 d, with the FTOC media being
changed once during the incubation. After this time, a single-cell
suspension of the lobes was prepared, and the thymocytes were ana-
lyzed by flow cytometry as described below.
Flow Cytometry. FITC-, PE–, and APC-conjugated anti–
mouse CD4, CD25, and CD8 were used for flow cytometric
analysis (purchased from PharMingen). Staining of cells was car-
ried out as described previously (51). In brief, thymic cell suspen-
sions were washed in FACS buffer (HBSS containing 1% BSA and
0.1% sodium azide) and incubated with antibodies (1:300 dilu-
tion) for 30 min on ice. The cells were then washed in FACS
buffer before analysis. Stained cells were analyzed with a FACS-
Calibur™ flow cytometer (Becton Dickinson). Analysis was per-
formed using CELLQuest software (Becton Dickinson); the data
were live gated by size and lack of propidium iodide uptake.
Luciferase and b-galactosidase Assay. Cells transfected with the
PathDetect reporter plasmids (Stratagene Inc.) were assayed for
luciferase and b-galactosidase activities using the Dual-Light re-
porter gene assay system (Tropix; Perkin Elmer-Applied Biosys-
tems) as previously described (50). In brief, the cells were lysed in
lysis buffer (40 mM tricine, pH 7.8, 50 mM NaCl, 2 mM EDTA,
1 mM MgSO4, 5 mM dithiothreitol, and 1% Triton X-100).
Supernatant (25 ml) was combined with an equal volume of
luciferase reaction buffer (30 mM tricine, pH 7.8, 3 mM ATP,
15 mM MgSO4, 1 mM coenzyme A, and 10 mM dithiothreitol),
and after addition of 1 mM luciferin, the sample was immediately
assayed for luciferase activity with a Lumat LB 9507 Luminometer
(Fisher Scientific Co.). To assay for b-galactosidase activity, Galac-
ton-Plus (substrate for b-galactosidase; Tropix) was added to each
tube after the luciferase assay was completed. The tubes were incu-
bated for 30–60 min at room temperature, and then Accelerator-II
(Tropix) was added to each tube and the samples were immediately
assayed for b-galactosidase activity, measured as light emission with
the Lumat LB 9507 Luminometer. Results represent the average
luciferase activity indexed for b-galactosidase activity. 
Results
Pre-TCR Complex Engagement Induces ERK-1/2 Phosphor-
ylation. To aid in deciphering the signaling pathways that
lead to the differentiative and proliferative events of b-selec-
tion, the phosphorylation status of ERK-1/2 was investi-
gated by performing Western blot analyses using an anti-
phospho-ERK-1/2 mAb. A SCID mouse–derived pre-T
cell line, SL-12.b12, preincubated with biotinylated anti–
TCR-b (H57-597) mAb, was stimulated for 1–30 min upon
cross-linking with avidin. Engagement of the pre-TCR com-
plex resulted in a rapid and transient phosphorylation of
ERK-1/2 (Fig. 1 A). Phosphorylation was observed as early
as 1 min but declined almost to background levels 5 min
after stimulation; subsequently, a secondary, weaker level
of phosphorylation was evident between 10 and 30 min
(Fig. 1 A). To control for protein loading, the total amount
of ERK-2 was assessed by Western blot with an anti–
ERK-2 antibody (Fig. 1 B).
To study whether the decline in phosphorylation of
ERK-1/2 at 5 min was specific to pre-TCR activation, we
performed a similar experiment with variants of the SL12
cell line expressing comparable levels of TCR b chain with
either a TCR a chain (mature TCR) or a pTa chain (pre-
TCR), as determined by flow cytometry (data not shown).
The TCR b chain on both cell lines was cross-linked for
1–30 min, and the phosphorylation status of ERK-1/2
was determined. In both cases, there was an attenuation of
ERK-1/2 phosphorylation levels at 5 min, indicating that
this phosphorylation pattern is characteristic of the SL-12
cell line (data not shown). These results indicate that en-
gagement of the pre-TCR on SL-12b.12 cells leads to the
phosphorylation of ERK-1/2, demonstrating the activation
of the Ras/Raf/MEK/ERK signaling cascade.
Reporter Plasmid Detection of ERK-1/2 Activation after Pre-
TCR Engagement. We sought to determine if the phos-
phorylation of ERK-1/2 observed upon cross-linking of
the pre-TCR (Fig. 1 A) leads to their activation. To this
end, we employed a reporter plasmid system (described in
Materials and Methods) that allows detection of ERK-1/2
activation within the cell. This system utilizes two plasmids:
a fusion activator plasmid (pFA-Elk), which encodes for
the transactivation domain of the ERK substrate, Elk-1
(residues 307–427), fused with the DNA-binding domain
of GAL4; and a luciferase reporter plasmid (pFR-Luc), which
encodes for the luciferase gene under the control of five GAL4
binding elements. Hence, in transfected cells, phosphorylation
of the Elk-1 fusion protein can be read in the form of lu-
ciferase activity. Accordingly, we transfected SL-12b.12 cells
with pFR-Luc, either alone or together with pFA-Elk.
The transfected cells were then stimulated with immobi-
lized anti-TCR-b mAb or with PMA and ionomycin.
Cells transfected with pFR-Luc alone displayed back-
ground luciferase activity (31 6 18 relative light units
[RLUs]). However, luciferase activity increased almost
850-fold above background levels in cells transfected with
pFR-Luc and pFA-Elk (26,221 6 1,119 RLUs; Fig. 2).
This elevation in luciferase activity may reflect low-level
Figure 1. ERK-1/2 is phosphorylated upon cross-linking of the pre-
TCR in the SL-12b.12 pre-T cell line. Lysates from SL-12b.12 cells
stimulated with 10 mg/ml biotinylated anti–TCR-b mAb H57-597 and
cross-linked with avidin (lanes 1, 2, 5, 10, and 30) or unstimulated cells
(lane 0) were prepared and resolved on a 10% SDS-PAGE under reduc-
ing conditions and subsequently immunoblotted with specific antibodies
against (A) phospho-ERK-1/2 and (B) ERK-2.1650 Pre-TCR–derived Signals Activate ERK In Vivo
constitutive ERK activity within SL-12b.12 cells (Fig. 1 A),
as it was blocked by the addition of the MEK1 inhibitor,
PD98059 (data not shown). Importantly, anti–TCR-b mAb
stimulation of pFR-Luc/pFA-Elk–transfected SL-12b.12
cells resulted in a fivefold increase in luciferase activity
compared with unstimulated cells (Fig. 2 A). This elevation
in luciferase activity was abrogated by the addition of
PD98059 (129% inhibition). These data indicate that en-
gagement of the pre-TCR complex results in the activation
of ERK and subsequent phosphorylation of the ERK-1/2
substrate, Elk-1 (Fig. 2 A).
Activation of pFR-Luc/pFA-Elk–transfected cells by
the addition of PMA/ionomycin induced a 20-fold stimu-
lation in luciferase activity over unstimulated cells (Fig. 2
B); again, addition of PD98059 curtailed this activity (data
not shown). As a control to demonstrate that ERK-1/2 acti-
vation can be efficiently detected with these reporter plas-
mids, pFR-Luc/pFA-Elk–transfected cells were also trans-
fected with a plasmid encoding a constitutively active MEK1,
pFC-MEK1. This serine/threonine kinase is responsible for
the phosphorylation and activation of ERK-1/2. These cells
showed maximal luciferase activity irrespective of PMA/
ionomycin treatment (Fig. 2 B), indicating that this re-
porter system provides a highly sensitive method for de-
tecting ERK activation.
Taken together, these results confirm that the ERK sig-
naling cascade is activated upon engagement of the pre-
TCR, as shown by the phosphorylation of ERK-1/2 (Fig.
1 A) and the phosphorylation/activation of the ERK-1/2
substrate, Elk-1 (Fig. 2 A), in the SL-12b.12 cell line.
Generation of DP Thymocytes in RAG-22/2 FTOCs Trans-
fected with TCR-b and Active p56lck Genes. An important
application of the above reporter plasmid system would be
to detect specific pre-TCR–mediated signals as they occur
within an intact thymus. Therefore, an accelerated DNA/
particle bombardment delivery system (gene gun) was adapted
to transfect thymocytes in FTOC (52). This approach allows
transfected cells to respond to normal microenvironmental
stimuli encountered during differentiation within the thy-
mic milieu (52, 53). We have previously used this method
to study transcriptional regulation events in the developing
fetal thymus (52).
The preservation of structural and functional integrity of
gene gun–transfected thymi was tested by allowing FTOCs
to complete a program of b-selection. Thus, RAG-22/2
mouse–derived FTOCs were gene gun transfected with
control DNA and cultured for 7 d, either alone (Fig. 3 A,
Control) or in the presence of anti-CD3 mAb (Fig. 3 A,
anti-CD3). Transfected FTOCs were then analyzed by flow
cytometry for evidence of differentiation to the DP stage
(17–19). This analysis revealed that the thymocytes from
anti-CD3–treated RAG-22/2 gene gun–transfected FTOCs
progressed to the DP stage, as indicated by upregulation of
CD8/CD4 (Fig. 3 A, anti-CD3). This differentiative event
involved the loss of CD25 cell surface expression and pro-
ceeded through a CD81 immature SP stage (Fig. 3 A, anti-
CD3). These results indicated that thymocytes and stromal
elements within gene gun–transfected thymic lobes remain
viable.
To determine the long-term developmental capacity of
transfected thymocytes, RAG-22/2 thymic lobes were gene
gun transfected with plasmids encoding either constitu-
tively active Lck (Lck[F505]) or a productively rearranged
TCR b chain. It has been previously shown in RAG2/2
Figure 2. Activation of the ERK signaling cascade upon stimulation of
SL-12b.12 cells with anti–TCR-b mAb (H57-597; A) or PMA/ionomy-
cin (B). SL-12b.12 cells were transfected with reporter plasmids as indi-
cated in the figure: pFR-Luc (10 mg), pFA-Elk (20 mg), and pFC-MEK1
(20 mg). All cells were transfected with a control b-galactosidase–encod-
ing plasmid (1 mg). The transfected cells were incubated overnight at
378C and then stimulated for 8 h with (A) immobilized anti–TCR-b or
(B) phorbol ester, PMA, and the calcium ionophore, ionomycin (10 ng/ml
of each). Cells were then lysed, and the lysates were assayed for luciferase
and b-galactosidase activity. The experiment shown is representative of
results carried out three times. Each experiment was carried out in tripli-
cate, and the luciferase activities shown are indexed against b-galactosi-
dase activity measured within each same sample.1651 Michie et al.
mice that introduction of transgenes encoding a kinase-
active Lck or a functionally rearranged TCR b chain in-
duced thymocyte proliferation and differentiation toward
the DP stage of development (39, 41). Indeed, these events
were also observed in gene gun–transfected RAG-22/2
FTOCs (Fig. 3 B). Flow cytometric analysis of Lck(F505)-
and TCR-b–transfected FTOCs after 7 d revealed that
thymocytes differentiated from the DN stage to the DP
stage, as evidenced by upregulation of CD4 and CD8 sur-
face expression and downregulation of CD25 surface ex-
pression (Fig. 3 B). The apparent difference in the levels of
CD8 surface expression in active Lck-transfected FTOCs
was due to the fact that the experiment shown was ana-
lyzed separately and a different set of fluorochrome-labeled
antibodies was used. These phenotypic changes are consis-
tent with differentiation events that occur after completion
of b-selection (Fig. 3 B; reference 5, 10–13).
Our finding that gene gun transfection of RAG-22/2
FTOCs with a functional TCR b chain resulted in the
normal developmental progression of DN thymocytes indi-
cated that a functional pre-TCR complex was generated
(39). These data imply that after gene gun transfection, the
formation of the pre-TCR results in signaling events that
occur during normal b-selection in vivo.
ERK Signaling Cascade Is Activated upon Formation of the
Pre-TCR in the Thymus. Because the cellular signaling pro-
cesses that underlie b-selection are not well defined, we
combined gene gun–mediated transfection of FTOCs with
the reporter plasmid system. In this way, the intracellular
signaling cascades that occur after pre-TCR formation can
be monitored in a biological time frame and within a rele-
vant in vivo setting. We hypothesized that gene gun–medi-
ated transfection of RAG-22/2 mouse–derived FTOCs
with a plasmid encoding a functionally rearranged TCR b
chain, together with reporter plasmids, would allow us to
capture de novo b-selection signaling events that occur af-
ter the generation of the pre-TCR.
Our results show that compared with FTOCs transfected
with pFR-Luc alone (Fig. 4), there was a slight elevation in
luciferase activity in FTOCs transfected with pFR-Luc/
pFA-Elk (6 6 1.8 vs. 59 6 17 RLUs; Fig. 4). This level of
luciferase activity may represent endogenous ERK-1/2 ac-
tivity present in transfected FTOCs.
To directly test our hypothesis, RAG-22/2 FTOCs were
gene gun transfected with reporter plasmids (pFR-Luc/
pFA-Elk) together with a plasmid encoding a functional
TCR b chain. Our analysis revealed an almost sixfold in-
crease in luciferase activity in FTOCs transfected with a
TCR-b plasmid as compared with FTOCs transfected
with the reporter plasmids alone (333 6 56 RLUs vs. 59 6
17; Fig. 4, TCR-b). A substantial luciferase activity was
also observed in FTOCs transfected with a constitutively
active MEK1 plasmid together with the reporter plasmids
(9,919 6 1,933 RLUs; Fig. 4, MEK1). The level of stimu-
lation observed in MEK1-transfected FTOCs demonstrates
the sensitive nature of this assay.
Several reports have suggested that the Ras/Raf/MEK/
ERK signaling cascade is involved at the b-selection stage
(13, 42, 43, 54). However, our data provides the first direct
evidence for coupling of the pre-TCR complex to the
ERK signaling cascade in vivo.
Activation of the ERK Cascade Requires Lck. Lck is thought
to play an essential role as a mediator of b-selection events
(15, 17, 24, 41, 55). Therefore, we investigated whether
Lck could activate the ERK signaling cascade in FTOCs.
To this end, FTOCs were gene gun transfected with a ki-
nase-active Lck together with the reporter plasmids. Fig. 5
shows that a sixfold increase in luciferase activity was ob-
served in FTOCs transfected with constitutively active Lck
Figure 3. Generation of CD41CD81 DP cells in RAG-22/2 FTOCs
gene gun transfected with plasmid encoding a constitutively active Lck or
a functional TCR b chain. Intact fetal thymic lobes removed from timed-
pregnant RAG-22/2 mice (day 14 of gestation) were used as targets for
DNA-covered gold particles as described in Materials and Methods. Fetal
thymi were gene gun transfected with (A) control DNA and incubated in
the absence (Control) or presence (anti-CD3) of 10 mg/ml anti-CD3 mAb
(145-2C11) or (B) plasmid encoding a constitutively active Lck (DLR,
750 ng) or plasmid encoding a functionally rearranged TCR b chain
(DLR, 250 ng). The transfected FTOCs were cultured for 7 d. After this
time, a single-cell suspension was prepared and thymocytes were analyzed
for surface expression of CD25, CD8, and CD4 by flow cytometry.1652 Pre-TCR–derived Signals Activate ERK In Vivo
(387 6 75 RLUs; Fig. 5). This level of luciferase activity is
comparable to the stimulation observed in TCR-b–trans-
fected FTOCs (Fig. 5, TCR-b).
To address whether the observed ERK activation after
the pre-TCR complex formation was dependent on Lck
activity, we took advantage of a plasmid encoding a domi-
nant negative Lck (Lck[R273]). This mutant form of Lck
has been shown to cause a dramatic block in T cell devel-
opment at the DN stage (15). Fig. 5 shows that transfection
of RAG-22/2 FTOCs with the reporter plasmids together
with plasmids encoding a TCR b chain and a kinase-nega-
tive Lck led to an attenuation of luciferase activity, as com-
pared with FTOCs transfected with TCR-b alone (84 6
56 vs. 333 6 56 RLUs; Fig. 5).
These results indicate that expression of the pre-TCR
complex by developing thymocytes activates the ERK sig-
naling cascade and that this activation is directly dependent
on Lck during thymocyte differentiation within the thymus.
Discussion
In this study, we demonstrate that formation and/or en-
gagement of the pre-TCR complex results in the activation
of the ERK signaling cascade. We have shown this in two
distinct systems: (a) in a SCID mouse–derived pre-T cell
line, SL-12b.12 (48), in which engagement of the pre-TCR
leads to phosphorylation and activation of ERK-1/2; and (b)
within the thymus, where formation of the pre-TCR in de-
veloping thymocytes induces ERK activation and phosphor-
ylation of the downstream substrate, Elk-1. Furthermore,
our findings confirm the central role of the nonreceptor ty-
rosine kinase Lck in b-selection by demonstrating that ERK
activation is strictly dependent on Lck function in vivo.
The ability to introduce reporter plasmids into develop-
ing thymocytes in vivo provides an important diagnostic
tool for the detection of signaling events during T cell de-
velopment in the thymus (Figs. 3 and 4). The significance
of this method is highlighted by the fact that, in the ab-
sence of the thymic microenvironment (i.e., cell suspen-
sion), thymocytes fail to respond to normal developmental
cues and undergo rapid programmed cell death (56, 57).
Indeed, transfection of thymocytes from RAG2/2 mice
with reporter plasmids revealed that cells in suspension fail
to respond when cotransfected with a plasmid encoding a
TCR b chain (data not shown). Thus, thymocytes in cell
suspension appear to be unresponsive to pre-TCR–medi-
ated signals, possibly due to the lack of stromal elements to
assist in this signaling. These results are consistent with pre-
vious data showing that anti-CD3 mAb–mediated differen-
tiation of RAG2/2 thymocytes to the DP stage in FTOC
does not occur when these thymocytes are treated in cell
suspension (58).
Figure 4. Activation of the ERK signaling cas-
cade in fetal thymic lobes gene gun transfected
with a plasmid encoding a functional TCR b
chain. Intact fetal thymic lobes removed from
timed-pregnant RAG2/2 mice (day 14 of gesta-
tion) were used as targets for DNA-covered gold
particles as described in Materials and Methods.
Fetal thymi were gene gun transfected with pFR-
Luc (DLR, 250 ng) and CMV-b-gal (DLR, 250
ng) and either pFA-Elk (DLR, 250 ng) alone or
together with TCR-b (DLR, 250 ng) or consti-
tutively active MEK-1 (DLR, 250 ng), as indi-
cated. The transfected lobes were then cultured
for 16–20 h. Cells were then lysed, and the lysates
were assayed for luciferase and b-galactosidase ac-
tivity. The data shown is an average of at least
five independent experiments. The individual lu-
ciferase activities were indexed against a constant
b-galactosidase activity.
Figure 5. Activation of ERK signaling cascade by the pre-TCR is de-
pendent on Lck function. Intact fetal thymic lobes removed from timed-
pregnant RAG2/2 mice (day 14 of gestation) were used as targets for
DNA-covered gold particles as described in Materials and Methods. Fetal
thymi were gene gun transfected with pFR-Luc (DLR, 250 ng) and
CMV-b-gal (DLR, 250 ng) and either pFA-Elk (DLR, 250 ng) alone or
together with constitutively active Lck (Lck[F505]; DLR, 750 ng), TCR-b
(DLR, 250 ng), or TCR-b (DLR, 250 ng) plus dominant negative Lck
(Lck[R273]; DLR, 750 ng), as indicated. The transfected lobes were then
cultured for 20–24 h. Cells were then lysed, and the lysates were assayed
for luciferase and b-galactosidase activity. The data shown is an average of
at least four independent experiments. The individual luciferase activities
were indexed against a constant b-galactosidase activity.1653 Michie et al.
The notion that the Ras/Raf/MEK/ERK signaling cas-
cade plays a central role during b-selection is supported by
data obtained from mice bearing targeted genetic deficien-
cies of key signaling molecules such as Lck/Fyn, ZAP-70/
Syk, LAT, or SLP-76 (24–26, 28–31). These mice dis-
played a block in T cell development at the DN stage, sug-
gesting that these molecules are essential for differentiation
to the DP stage of development (24–26, 28–31). However,
several contradicting reports using transgenic mice carry-
ing either constitutively active or dominant negative mem-
bers of these signaling molecules have left the involvement
of this pathway unresolved. Studies introducing constitu-
tively active Lck, Ras, and Raf into RAG2/2 mice also in-
dicate that the Ras/Raf pathway is crucial at this stage of
development (41–43). In contrast, studies using transgenic
mice carrying dominant negative forms of Ras (Ha-RasN17)
(45), Raf (46), and MEK-1 (47) failed to support a role for
these signaling molecules during b-selection. In this re-
gard, it is important to note that mice carrying a dominant
negative Lck transgene displayed varying degrees of DN
to DP thymocyte development arrest directly correlating
with the levels of transgene expression (15). Thus, the
conflicting results obtained using dominant negative mole-
cules may reflect their ability to be sufficiently expressed at
the appropriate stage of development. In addition, studies
using retroviral infection of thymocytes with dominant
negative MEK-1 showed a perturbation in the transition
of thymocytes from the DN to DP stage, suggesting that
the inhibitory effectiveness of dominant negative mole-
cules appears to be dependent on the experimental system
used (54).
Although several studies have indirectly supported the
importance of the Ras/Raf/MEK/ERK-mediated signals
downstream of the pre-TCR, in our system, the fact that the
detection of ERK activation is predicated by the expression
of the pre-TCR within individually transfected developing
thymocytes directly links the pre-TCR to the activation of
these kinases. Thus, this study provides the first evidence for
the pre-TCR being responsible for the generation of specific
downstream signals within the thymus (Fig. 4) and shows
that Lck acts proximally to the nascent pre-TCR complex,
leading to the subsequent activation of ERK (Fig. 5).
The transcription factor Elk-1 has been shown to be
phosphorylated by ERK-1/2, although more recently it has
been demonstrated that JNK (c-Jun NH2-terminal kinase)
also has the ability to phosphorylate and activate Elk-1 (59–
61). However, mouse models with gene-targeted disrup-
tions of key signaling components of the JNK signaling
pathway (JNK2 and stress-activated protein kinase kinase 1)
did not reveal any abnormalities in b-selection events (62–
64). In this regard, our data with the SCID mouse–derived
pre-T cell line SL-12b.12 show that engagement of the
pre-TCR results in ERK phosphorylation and activation of
the ERK substrate, Elk-1 (Figs. 1 and 2), and that this can
be blocked by addition of the MEK1 inhibitor, PD98059.
Together, these data indicate that, in this setting, Elk-1 is
specifically activated by ERK.
Pre-TCR signals can be experimentally bypassed by
introducing constitutively active mutants of certain signal-
ing components, inducing b-selection–mediated events. In-
terestingly, the introduction of an activated form of Ras
(Ha-RasV12) or Raf-1 (Raf-CAAX), although allowing the
differentiation of RAG2/2 thymocytes to the DP stage,
failed to establish allelic exclusion at the TCR-b locus
when introduced into wild-type mice (43, 65). This indi-
cates that although certain b-selection outcomes are me-
diated by the Ras/Raf pathway, distinct pre-TCR–derived
signals upstream of Raf are responsible for the control of
allelic exclusion. Therefore, it is interesting to note that
RAG2/2 FTOCs retrovirally infected with constitutively
active MEK1 do not differentiate to the DP stage of devel-
opment (54). This finding suggests that Raf may activate
additional signaling pathways enabling developing thy-
mocytes to undergo full differentiation to the DP stage.
Therefore, the intrathymic signal detection system devel-
oped here will allow for detailed studies of distal signaling
events activated by the pre-TCR, facilitating the elucida-
tion of potential signaling branchpoints.
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